Philips introduces SmartIQ coronary imaging technology
Royal Philips has announced the launch of SmartIQ, which the company describes as a breakthrough...
EuroPCR 2026: DynamX bioadaptor demonstrates significantly lower event rates than drug-eluting stent
Elixir Medical has announced four-year results from the large 445-patient BIOADAPTOR randomised cont...
EuroPCR 2026: Routine PCI provides “limited advantage” compared with medical therapy following TAVI
Routine percutaneous coronary intervention (PCI) may provide only “limited advantage” compared w...
EuroPCR 2026: SMART trial three-year data demonstrate superiority for Evolut TAVI system
Medtronic today released the three-year results of the SMall Annuli Randomized To Evolut or Sapi...
